Anthony Pagano

Insider activity · 24 months0 buys1 saleCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 1 saleMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (5 ops.)

€9.6M

Latest filing published 20 Feb 2026 for Genmab A/S, €218k.

Filing timeline

BuySale

Anthony Pagano

Insider track record

Disclosed buys

Disclosed sells

Signal history

Anthony Pagano: trading record in brief

Anthony Pagano discloses dealings in Genmab A/S to Finanstilsynet DK. In total, 9 filings cover trades dated from 11 May 2021 to 19 February 2026.

The open-market record consists of 5 sales worth €9.6M, with no purchase. 2026 to date brings no purchases and 1 sale.

On 20 February 2026 came the latest disclosure, an open-market sale for €218k in Genmab A/S. Publication is fast: at least half of the trades appear on Finanstilsynet DK on the same day. The legal deadline for notifying a trade is three business days (MAR article 19). A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from Finanstilsynet DK disclosures alone and does not predict where the share price will go.